(2S,3S)-2-amino-3-methylpentanoic acid

CC[C@H](C)[C@@H](C(=O)O)N

InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1

AGPKZVBTJJNPAG-WHFBIAKZSA-N

l-isoleucine; Isoleucine; 73-32-5; (2S,3S)-2-Amino-3-methylpentanoic acid; 2S,3S-Isoleucine; (S)-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; L-(+)-Isoleucine; H-Ile-OH; erythro-L-Isoleucine; L-Ile; ISOLEUCINE, L-; alpha-Amino-beta-methylvaleric acid; Isoleucine (VAN); Isoleucinum [Latin]; Isoleucina [Spanish]; Norvaline, 3-methyl-; Valeric acid, 2-amino-3-methyl-; L-Norvaline, 3-methyl-, erythro-; Acetic acid, amino-sec-butyl-; Pentanoic acid, 2-amino-3-methyl-; CCRIS 5229; iso-leucine; ile; (2S,3S)-alpha-Amino-beta-methyl-n-valeric acid; NSC 46708; (2S,3S)-alpha-Amino-beta-merthylvaleric acid; (S-(R*,R*))-2-Amino-3-methylpentanoic acid; FEMA No. 3295; (2S,3S)-alpha-Amino-beta-merthyl-n-valeric acid; 2-Amino-3-methylpentanoic acid, (S-(R*,R*))-; Acetic acid, amino(1-methylpropyl)-, (R*,R*)-; (2S,3S)-2-Amino-3-methylpentanoicacid; Isoleucine (L-Isoleucine); 5HX0BYT4E3; Pentanoic acid, 2-amino-3-methyl-, (S-(R*,R))-; FEMA NO. 4675; CHEBI:17191; [S-(R*,R*)]-2-Amino-3-methylpentanoic acid; 2S-Amino-3S-methylpentanoic acid; Isoleucine, DL-; DL-Allo-isoleucine; NSC-46708; 04Y7590D77; MFCD00064222; (2S,3S)-alpha-Amino-beta-methylvaleric acid; Pentanoic acid, 2-amino-3-methyl-, (2S,3S)-; Isoleucina; Isoleucinum; Isoleucine [USAN:INN]; MFCD00004268; H-lle-OH; (2S,3S)-2-amino-3-methylpentanoate; EINECS 200-798-2; UNII-5HX0BYT4E3; NSC-9958; NSC46708; laevo-isoleucine; (2S,3S)-2-amino-3-methyl-Pentanoic acid; L-iso-leucine; HSDB 7798; (L)-Isoleucine; L- iso-Leucine; Isoleucine [USAN:USP:INN:BAN]; UNII-04Y7590D77; Isoleucine (USP); NSC 9958; EINECS 207-139-8; H-Ile; Ile-OH; L-Isoleucine,(S); (+)-L-isoleucine; L-[14C]Isoleucine; (2S,3S)-a-Amino-b-methylvaleric acid; (+/-)-erythro-2-Amino-3-methylpentanoic acid; L-Isoleucine, 99%; ISOLEUCINE [II]; ISOLEUCINE [MI]; (2S,3S)-a-Amino-b-methyl-n-valeric acid; AI3-18474; L-Isoleucine (JP17); ISOLEUCINE [INN]; ISOLEUCINE [HSDB]; ISOLEUCINE [INCI]; ISOLEUCINE [USAN]; ISOLEUCINE DL-FORM; 2-Amino-3-methylvalerate; ISOLEUCINE [VANDF]; Isoleucine, L- (8CI); bmse000041; bmse000866; bmse000884; 2-amino-3-methylpentanoate; ISOLEUCINE [MART.]; L-Isoleucine (H-lle-OH); L-ISOLEUCINE [FCC]; L-ISOLEUCINE [JAN]; SCHEMBL8869; DL-ISOLEUCINE [FCC]; ISOLEUCINE [WHO-DD]; sec-C4H9CH(NH2)COOH; Acetic acid, amino-s-butyl-; DL-ISOLEUCINE [FHFI]; L-Isoleucine (H-L-Ile-OH); L-ISOLEUCINE [USP-RS]; GTPL3311; CHEMBL1233584; DTXSID1047441; DTXSID2046882; ISOLEUCINE DL-FORM [MI]; L-Isoleucine: D-allo-isoleucine; BDBM18140; Norvaline, 3-methyl-, erythro-; ISOLEUCINE [EP MONOGRAPH]; ISOLEUCINE [USP MONOGRAPH]; L-Isoleucine, 99%, FCC, FG; Pharmakon1600-01301004; (2S,3S)-a-Amino-b-methylvalerate; HY-N0771; ZINC3581355; LMFA01100047; NSC760109; s3752; L-Isoleucine, Vetec(TM), 98.5%; AKOS015842027; (2S,3S)-a-Amino-b-methyl-n-valerate; AM81842; CCG-266114; CS-W018502; DB00167; FD20022; NSC-760109; (2S,3S)-2-amino-3-methyl-Pentanoate; VALINE IMPURITY B [EP IMPURITY]; (2S,3S)-alph-Amino-beta-methylvalerate; LEUCINE IMPURITY A [EP IMPURITY]; (2S,3S)-alpha-Amino-beta-methylvalerate; AC-34995; AS-11616; BP-20357; (2S,3S)-alpha-Amino-beta-merthylvalerate; 064l222; [S-(R*,R*)]-2-Amino-3-methylpentanoate; L-Isoleucine, BioUltra, >=99.5% (NT); (2S,3S)-alph-Amino-beta-methylvaleric acid; (2S,3S)-alpha-Amino-beta-methyl-n-valerate; I0181; (2S,3S)-alpha-Amino-beta-merthyl-n-valerate; EN300-52623; L-Isoleucine, SAJ special grade, >=99.0%; C00407; D00065; L-Isoleucine, reagent grade, >=98% (HPLC); M03002; L-Isoleucine, Vetec(TM) reagent grade, >=98%; L-Isoleucine, Cell Culture Reagent (H-L-Ile-OH); Q484940; Q-201311; (2S,3S)-.alpha.-Amino-.beta.-methyl-n-valeric acid; .alpha.-Amino-.beta.-methylvaleric acid, (2S,3S)-; Pentanoic acid, 2-amino-3-methyl-, [S-(R*,R*)]-; F8880-9085; Z756427442; Isoleucine, European Pharmacopoeia (EP) Reference Standard; L-Isoleucine, certified reference material, TraceCERT(R); E46116A2-987C-4709-9E80-A64DA838D5A1; L-Isoleucine, United States Pharmacopeia (USP) Reference Standard; L-Isoleucine, Pharmaceutical Secondary Standard; Certified Reference Material; (S,S)-2-amino-3-methyl-pentanoicacid;(s,s)-isoleucine;[S-(R*,R*)]-2-Amino-3-methylpentanoic acid; 1160211-67-5; L-Isoleucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%